Lobbyist Public Search Mass. state house
Records prior to registration year 2005 are not available online.

Contact the Lobbyist Division here for assistance. 		Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
Your comments are welcome:  submit feedback
Disclosure reporting details
Back to search detail summary
Lobbyist disclosure reporting period:   01/01/2022 - 06/30/2022
Lobbyist name Ashley Calabrese   
Business name Novartis Services, Inc.
Address 1176 North Main St   
City, state, zip code West Hartford, CT 06117         
Country US
Agent type Both
Phone 203-410-7936
 
 
Operating Expenses
No operating expenses were filed for this disclosure reporting period.
 
Activities, Bill Numbers and Titles
Client: Novartis Services, Inc.
Total amount paid by client; lobbyist is unable to report compensation at activity level: $5,925.00
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
House Bill 729 An Act to ensure prescription drug cost transparency and affordability Neutral $0.00 N/A
House Bill 2395 An Act relative to sickle cell disease Neutral $0.00 N/A
Senate Bill 1465 An Act to reduce healthcare costs by promoting non-biased prescriber education Neutral $0.00 N/A
House Bill 1155 An Act to ensure access to generic medications Neutral $0.00 N/A
Senate Bill 243 An Act relative to preventing price gouging during an emergency Neutral $0.00 N/A
Senate Bill 2651 An Act relative to pharmaceutical access, costs and transparency Neutral $0.00 N/A
House Bill 1059 An Act relative to patient financial protection Neutral $0.00 N/A
House Bill 4465 An Act to reduce healthcare costs by promoting non-biased prescriber education Neutral $0.00 N/A
Senate Bill 2058 An Act designating the last day of February as rare disease day in the Commonwealth Neutral $0.00 N/A
House Bill 1311 An Act relative to step therapy and patient safety Neutral $0.00 N/A
Senate Bill 790 An Act to define modest meals and refreshments in prescriber education settings Neutral $0.00 N/A
House Bill 2377 An Act to permit the wholesale importation of prescription drugs into the Commonwealth Neutral $0.00 N/A
Senate Bill 804 An Act to promote transparency and prevent price gouging of pharmaceutical drug prices Neutral $0.00 N/A
House Bill 1237 An Act relative to non-medical switching Neutral $0.00 N/A
Senate Bill 650 An Act relating to patient cost, benefit and coverage information, choice, and price transparency Neutral $0.00 N/A
House Bill 1237 An Act relative to non-medical switching Neutral $0.00 N/A
Senate Bill 654 An Act relative to out-of-pocket expenses for prescription drug coverage Neutral $0.00 N/A
House Bill 1254 An Act relative to promoting comprehensive transparency in the pharmaceutical industry Neutral $0.00 N/A
Senate Bill 756 An Act relative to step therapy and patient safety Neutral $0.00 N/A
House Bill 1190 An Act relating to patient cost, benefit, and coverage information, choice, and price transparency Neutral $0.00 N/A
Senate Bill 627 An Act relative to promoting healthcare access and affordability for patients Neutral $0.00 N/A
Senate Bill 4701 An Act making appropriations for the fiscal year 2023 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Neutral $0.00 N/A
House Bill 1053 An Act relative to consumer deductibles Neutral $0.00 N/A
House Bill 3101 An Act designating the last day of February as rare disease day in the Commonwealth Neutral $0.00 N/A
Senate Bill 1924 An Act closing a corporate tax haven loophole Neutral $0.00 N/A
House Bill 1272 An Act to promote transparency in prescription drug prices Neutral $0.00 N/A
Senate Bill 771 An Act relative to pharmaceutical access, costs and transparency Neutral $0.00 N/A
House Bill 1278 An Act relative to prescription drug price transparency Neutral $0.00 N/A
Senate Bill 785 An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern Neutral $0.00 N/A
House Bill 1237 An Act relative to non-medical switching Neutral $0.00 N/A
Senate Bill 736 An Act relative to promoting comprehensive transparency in the pharmaceutical industry Neutral $0.00 N/A
House Bill 1307 An Act establishing a study to examine the feasibility of state manufactured generic prescription drugs Neutral $0.00 N/A
Senate Bill 786 An Act to bring down the cost of prescription drugs Neutral $0.00 N/A
House Bill 1237 An Act relative to non-medical switching Neutral $0.00 N/A
Senate Bill 728 An Act relative to pharmaceutical gag clauses Neutral $0.00 N/A
House Bill 1224 An Act relative to promoting healthcare access and affordability for patients Neutral $0.00 N/A
Senate Bill 644 An Act relative to consumer deductibles Neutral $0.00 N/A
Senate Bill 2774 An Act investing in the future of our health Neutral $0.00 N/A
    Total amount $0.00  
 
Meals, Travel, and Entertainment Expenses
No meals, travel, or entertainment expenses were filed for this disclosure reporting period.
 
Additional Expenses
No additional expenses were filed for this disclosure reporting period.
 
Campaign Contributions
No campaign contributions were filed for this disclosure reporting period.
Close this page
William Francis Galvin Secretary of the Commonwealth of Massachusetts
One Ashburton Place
Boston, MA   02108

1-800-392-6090
cis@sec.state.ma.us

Connect with Us

Terms and Conditions     Accessibility Statement